Cargando…

Targeting Angiogenesis in Childhood Sarcomas

Angiogenesis and vasculogenesis constitute two processes in the formation of new blood vessels and are essential for progression of solid tumors. Consequently, targeting angiogenesis, and to a lesser extent vasculogenesis, has become a major focus in cancer drug development. Angiogenesis inhibitors...

Descripción completa

Detalles Bibliográficos
Autores principales: Bid, Hemant K., Houghton, Peter J.
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3005857/
https://www.ncbi.nlm.nih.gov/pubmed/21197468
http://dx.doi.org/10.1155/2011/601514
_version_ 1782194141930717184
author Bid, Hemant K.
Houghton, Peter J.
author_facet Bid, Hemant K.
Houghton, Peter J.
author_sort Bid, Hemant K.
collection PubMed
description Angiogenesis and vasculogenesis constitute two processes in the formation of new blood vessels and are essential for progression of solid tumors. Consequently, targeting angiogenesis, and to a lesser extent vasculogenesis, has become a major focus in cancer drug development. Angiogenesis inhibitors are now being tested in pediatric populations whereas inhibitors of vasculogenesis are in an earlier stage of development. Despite the initial enthusiasm for targeting angiogenesis for treatment of cancer, clinical trials have shown only incremental increases in survival, and agents have been largely cytostatic rather than inducing tumor regressions. Consequently, the role of such therapeutic approaches in the context of curative intent for childhood sarcomas is less clear. Here we review the literature on blood vessel formation in sarcomas with a focus on pediatric sarcomas and developments in targeting angiogenesis for treatment of these rare cancers.
format Text
id pubmed-3005857
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-30058572010-12-30 Targeting Angiogenesis in Childhood Sarcomas Bid, Hemant K. Houghton, Peter J. Sarcoma Review Article Angiogenesis and vasculogenesis constitute two processes in the formation of new blood vessels and are essential for progression of solid tumors. Consequently, targeting angiogenesis, and to a lesser extent vasculogenesis, has become a major focus in cancer drug development. Angiogenesis inhibitors are now being tested in pediatric populations whereas inhibitors of vasculogenesis are in an earlier stage of development. Despite the initial enthusiasm for targeting angiogenesis for treatment of cancer, clinical trials have shown only incremental increases in survival, and agents have been largely cytostatic rather than inducing tumor regressions. Consequently, the role of such therapeutic approaches in the context of curative intent for childhood sarcomas is less clear. Here we review the literature on blood vessel formation in sarcomas with a focus on pediatric sarcomas and developments in targeting angiogenesis for treatment of these rare cancers. Hindawi Publishing Corporation 2011 2010-12-09 /pmc/articles/PMC3005857/ /pubmed/21197468 http://dx.doi.org/10.1155/2011/601514 Text en Copyright © 2011 H. K. Bid and P. J. Houghton. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Bid, Hemant K.
Houghton, Peter J.
Targeting Angiogenesis in Childhood Sarcomas
title Targeting Angiogenesis in Childhood Sarcomas
title_full Targeting Angiogenesis in Childhood Sarcomas
title_fullStr Targeting Angiogenesis in Childhood Sarcomas
title_full_unstemmed Targeting Angiogenesis in Childhood Sarcomas
title_short Targeting Angiogenesis in Childhood Sarcomas
title_sort targeting angiogenesis in childhood sarcomas
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3005857/
https://www.ncbi.nlm.nih.gov/pubmed/21197468
http://dx.doi.org/10.1155/2011/601514
work_keys_str_mv AT bidhemantk targetingangiogenesisinchildhoodsarcomas
AT houghtonpeterj targetingangiogenesisinchildhoodsarcomas